Entries of Dinjens, Winand N. M. on the publication server
 | Up a level |
Jump to: Article
Number of items: 2.
Article
Doeveren, Thomas, Nakauma‐Gonzalez, Jose A. 
, Mason, Andrew S., Leenders, Geert J. L. H. , Zuiverloon, Tahlita C. M., Zwarthoff, Ellen C., Meijssen, Isabelle C., Made, Angelique C., Heijden, Antoine G., Hendricksen, Kees, Rhijn, Bas W. G. , Voskuilen, Charlotte S., Riet, Job, Dinjens, Winand N. M., Dubbink, Hendrikus J., Werken, Harmen J. G. and Boormans, Joost L.
(2021)
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
International Journal of Cancer 148 (4), pp. 981-987.
Fulltext not available.
, Mason, Andrew S., Leenders, Geert J. L. H. , Zuiverloon, Tahlita C. M., Zwarthoff, Ellen C., Meijssen, Isabelle C., Made, Angelique C., Heijden, Antoine G., Hendricksen, Kees, Rhijn, Bas W. G. , Voskuilen, Charlotte S., Riet, Job, Dinjens, Winand N. M., Dubbink, Hendrikus J., Werken, Harmen J. G. and Boormans, Joost L.
(2021)
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
International Journal of Cancer 148 (4), pp. 981-987.
Fulltext not available.
van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang and Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), pp. 1645-1653.
Fulltext not available.
, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang and Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), pp. 1645-1653.
Fulltext not available.